CMR Surgical
CMR Surgical is a British medical-device company headquartered in Cambridge, UK, founded in 2014 (as Cambridge Medical Robotics). It develops Versius, a small, modular and portable robot-assisted surgical system used across urology, general, gynaecological and thoracic surgery, and Versius Plus, its next-generation platform cleared by the US FDA in December 2025. More than 45,000 patients have been treated globally, making Versius one of the most widely used soft-tissue robotic surgery platforms. CMR reached unicorn status in 2019 and raised a $600M Series D at a $3B valuation in 2021, backed by SoftBank Vision Fund 2, GE Healthcare, ABB Technology Ventures and others. Its digital ecosystem (Versius Connect, Versius Team, Versius Clinical Insights) is a login-gated clinical surface; CMR publishes no public developer API, OpenAPI, SDKs or developer portal.
CMR Surgical is profiled on the APIs.io network. Tagged areas include Company, Health Tech, Medical Devices, Surgical Robotics, and Robotics.
CMR Surgical’s developer surface includes engineering blog, support, and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API